Antonio Valvano

Antonio Valvano

Auto-generated profile, based on publicly available information

Antonio Valvano

Department of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Atherosclerosis
Verified
Journal Article
Closed access
UOUgo Oliviero
Ugo Oliviero
GBGiovanni Bonadies
Giovanni Bonadies
VAValentina Apuzzi
Valentina Apuzzi
MFMaria Foggia
Maria Foggia
GBGiorgio Bosso
Giorgio Bosso
LSLuigi Saccà
Luigi Saccà

1 February 2010 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
UOUgo Oliviero
Ugo Oliviero
Antonio CittadiniAntonio Cittadini
Antonio Cittadini
GBGiorgio Bosso
Giorgio Bosso
MCManuela Cerbone
Manuela Cerbone
AVAntonio Valvano
Antonio Valvano
MSMariacarolina Salerno
Mariacarolina Salerno
Objective Abnormalities in haematological parameters have been noted in patients with thyroid diseases. Nevertheless, the exact mechanism of thyroid hormones' (THs) action on human haematopoiesis is still not entirely clear. Design The influence of THs through TH receptors (TRα-1 and TRβ-1) on haematopoiesis in patients with hypo- and hyperthyroidism was analysed. Methods TR gene expression at the mRNA and protein levels in human CD34+-enriched haematopoietic progenitor cells (HPCs) obtained from the peripheral blood of patients with thyroid disorders and healthy volunteers was analysed. The cell populations were also investigated for clonogenic growth of granulocyte macrophage-colony forming units and erythrocyte-burst forming units (BFU-E). The level of apoptosis was determined by annexin V/propidium iodide staining and quantitative RT-PCR. Results The studies revealed that hypo- and hyperthyroidism modify TR gene expression in HPCs in vivo. TH deficiency resulted in a decrease in total blood counts and clonogenic potential of BFU-E. In contrast, hyperthyroid patients presented increased clonogenic growth and BFU-E number and significantly higher expressions of cell cycle-regulating genes such as those for PCNA and cyclin D1. Finally, an increase in the frequency of apoptotic CD34+-enriched HPCs in hypo- and hyperthyroidism with a modulation of apoptosis-related genes was detected. Conclusions The following conclusions were derived: i) TR expression in human haematopoietic cells depends on TH status, ii) both hypo- and hyperthyroidism significantly influence clonogenicity and induce apoptosis in CD34+-enriched HPCs and iii) the molecular mechanism by which THs influence haematopoiesis might provide a basis for designing novel therapeutic interventions in thyroid diseases.

1 December 2015 in Atherosclerosis
Verified
Journal Article
Closed access
AVAntonio Valvano
Antonio Valvano
GBGiorgio Bosso
Giorgio Bosso
VAValentina Apuzzi
Valentina Apuzzi
FRFilippo Riccone
Filippo Riccone
LSLuigi Saccà
Luigi Saccà
UOUgo Oliviero
Ugo Oliviero

1 March 2020 in Journal of Cardiovascular Medicine
Verified
Journal Article
Closed access
GBGiorgio Bosso
Giorgio Bosso
AVAntonio Valvano
Antonio Valvano
FGFranco Guarnaccia
Franco Guarnaccia
BFBiagio Fimiani
Biagio Fimiani
VCVincenzo Carbone
Vincenzo Carbone
UOUgo Oliviero
Ugo Oliviero
Background and aim: The Adherence to Guidelines in the Treatment of patients with Chronic Heart Failure trial showed a poor adherence to the current therapeutic guidelines in 660 chronic heart failure (CHF) patients. The second phase, Adherence to Guidelines in the Treatment of patients with Chronic Heart Failure follow-up, was aimed to determine if periodic echocardiographic evaluations could improve the prognosis of CHF patients and/or increase the adherence to the guidelines. Material and methods: Among 528 CHF patients with reduced ejection fraction from the ALERT registry, 436 patients accepted to participate in the second phase of the study between February and September 2013 and completed the 3-year follow-up phase between February and September 2016. They were randomized into two groups: Group A (n = 218) followed by clinical evaluation and ECG every 3 months, and echocardiography every 6 months and Group B (n = 218) monitored only with clinical evaluation and ECG every 3 months. Results: The number of vascular events that occurred resulted as similar in both the groups: there were 78 hospitalizations (37 in Group A vs. 41 in Group B); 9 home-treated vascular events (4 in Group A and five in Group B); and 16 cardiovascular deaths (9 and 7, respectively). The adherence to the guidelines at the end of the trial resulted as significantly improved in both the groups in comparison with the basal evaluation, without differences between the two groups. Conclusion: A strict follow-up of CHF patients was associated with a lower number of events and an improvement in the adherence to the guidelines. Periodic echocardiography does not modify these results.

17 June 2020 in Angiology
Verified
Journal Article
Closed access
PDF file
GBGiorgio Bosso
Giorgio Bosso
AVAntonio Valvano
Antonio Valvano
VAValentina Apuzzi
Valentina Apuzzi
VMValentina Mercurio
Valentina Mercurio
VSValeria Di Simone
Valeria Di Simone
UOUgo Oliviero
Ugo Oliviero
Vascular function in dilated cardiomyopathy of different etiology has been poorly investigated. Moreover, reference values of flow-mediated dilation (FMD) in chronic heart failure (CHF) need to be updated according to the new standardized protocols. We characterized the vascular impairment in different stages of post-ischemic dilated cardiomyopathy (PI-DC) or idiopathic dilated cardiomyopathy (I-DC). Eighty consecutive outpatients with CHF in different New York Heart Association (NYHA) classes (45 PI-DC, 35 I-DC) and 50 control subjects underwent FMD and brachial distensibility coefficient measurement. Patients with CHF showed a marked impairment in FMD compared with controls that worsened from classes NYHA I-II to III-IV, independently of etiology (P < .05). New York Heart Association I-II PI-DC patients showed a worse FMD compared with NYHA I-II I-DC patients (P < .05). Brachial distensibility coefficient values were significantly lower in patients with CHF compared with controls (P < .001) without differences between PI-DC and I-DC. In conclusion, advanced CHF is characterized by vascular impairment that is independent of etiology. In the early stages of CHF, endothelial dysfunction is more severe in patients with PI-DC compared with I-DC probably due to the high cardiovascular risk profile. In I-DC, vascular function impairment is independent of cardiovascular risk factors and could participate in the pathogenesis of I-DC.

1 March 2020 in International Angiology
Verified
Journal Article
Closed access
AVAntonio Valvano
Antonio Valvano
GBGiorgio Bosso
Giorgio Bosso
VAValentina Apuzzi
Valentina Apuzzi
VMValentina Mercurio
Valentina Mercurio
VSValeria Di Simone
Valeria Di Simone
UOUgo Oliviero
Ugo Oliviero
Background: Carotid dolicoarteriopathies (CDA) are a common finding during the carotid ultrasound or angiography, but their potential role in the development of cerebrovascular diseases is still unclear. Aim of this study is to clarify the possible relationship between CDA and the occurrence of cerebral events. Methods: We performed a retrospective analysis on 2124 hypertensive patients with high cardiovascular risk that underwent carotid ultrasound from January 2000 to December 2008. Follow-up data on cerebrovascular events (transient ischemic attack and/or stroke occurrence) at 10 years were collected. Results: The global prevalence of CDA in the study population was 12.9% (274/2124), and carotid kinking was more frequent in females and in the left carotid axis. The percentage of cerebrovascular events among hypertensive patients with CDA was similar to those occurred in the group of patients without CDA (10.94% vs. 10.97%, P=NS), with no differences in the number of strokes (8.39% vs. 8.38% P=NS) and TIA (2.55% vs. 2.59% P=NS). Conclusions: CDA are not associated with a major occurrence of cerebrovascular events in a high-risk population of hypertensives.